I have deliberately stayed away from this subject.
At the time of IER 2 being released, I ran updated numbers (cash on hand) on what information was available in IER 1. My fair value range was $1.79 to $2.08.
Net Cash levels are pretty much the same.
The updated JORC statement will not deliver 1 cent of extra value to shareholders. I was surprised they released it prior to the takeover being completed, but given the contents it didn't surprise.
I believe it would of been different, if it were being produced for other reasons.
There were a number of elements in it that were worth further examination, but I haven't contacted the company as yet. I do have a number of questions noted down.
It will come down to whether the new IE works on a 'control' basis, or applies a discount due to the large holding held by Taurus.
Hopefully the offer is high enough that it will be too good to refuse. Surely they don't want to go to Court.
There is also the fact that the Taurus fund was due to wind up in March 2019.
- Forums
- ASX - By Stock
- Ann: Notice of Extraordinary General Meeting/Proxy Form
I have deliberately stayed away from this subject. At the time...
Featured News
Add RRP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online